Visit Us on XBlood Podcast Features “N-glycosylation as a therapeutic vulnerability in CALR-mutant MPN”September 15, 2022Read moreAnna Marneth and Ann Mullally Featured in Wyss Institute Article “Deconstructing the mechanics of bone marrow disease”July 11, 2022Read moreFrederike received a Leukemia & Lymphoma Society Fellow Award, 2022May 3, 2022Read moreJonas was selected to present an oral EHA abstract in June 2022May 3, 2022Read moreBenjamin was awarded a scholarship from the German Cancer Aid (Deutsche Krebshilfe), 2021May 3, 2022Read moreJonas was awarded a Special Fellowship by The Leukemia & Lymphoma Society, 2021May 3, 2022Read moreAnna was promoted to Instructor at HMSApril 1, 2022Read moreAnna presented an oral abstract at ASH 2021December 12, 2021Read moreAnna is awarded LLS Fellow Award and DoD Horizon AwardMay 5, 2020Read moreFrederike is awarded a fellowship fund from the DFGMay 1, 2020Read moreMullally lab members go to Cold Spring Harbor Laboratory RetreatApril 22, 2020Read moreJonas is the 2020 laureate of the Franziska-Kolb foundation designated to foster researchers in leukemia.February 7, 2020Read morePatty presented her undergraduate thesis and received a poster pitch award at the New England Immunology Conference.October 13, 2019Read moreQ&A with Brigham Principal Investigator and Hematologist/Oncologist Ann MullallyApril 4, 2018Read moreDr. Mullally speaks at ESH MPN conference in Estoril, PortugalOctober 17, 2016Read moreAnn Mullally receives Clinical Investigator Continuation GrantJuly 1, 2016Read moreMutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationMarch 7, 2016Read moreDr. Shannon Elf presents a Late Breaking Abstract at the Annual ASH ConferenceDecember 1, 2015Read more Dec 2022: Frederike and Anna presented abstracts at ASH 2022 Dec 2022: Anna started her own lab in Netherlands Feb 2023: Jonas promoted to Instructor at Harvard Medical School Feb 2023: Publication of Leukemia Paper
